Speaker Profile
Ph.D., Nobel Laureate in Chemistry & Founding, Scientific and Managing Director, Max Planck Unit for the Science of Pathogens
Biography
Emmanuelle Charpentier is a pioneering microbiologist, geneticist, and biochemist whose work reshaped modern biology and medicine. She is best known for uncovering key mechanisms of the bacterial CRISPR-Cas immune system and, with Jennifer Doudna, developing CRISPR-Cas9 as a programmable genome-editing technology. Their discovery transformed the ability to precisely modify DNA, opening new paths for biomedical research, diagnostics, agriculture, and therapeutic development. Charpentier’s research has bridged fundamental microbiology and translational impact, revealing how bacteria regulate virulence and adapt to their environment while creating one of the most powerful tools in the life sciences. Her career across Europe reflects a rare mix of curiosity-driven science, institutional leadership, and field-changing translation. She is the Founding, Scientific and Managing Director of the Max Planck Unit for the Science of Pathogens in Berlin. In 2020, she received the Nobel Prize in Chemistry, shared with Doudna, for the development of a method for genome editing.
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
Catriona Jamieson, UCSD
Opening talk
• Catriona Jamieson, UCSD
PMWC Award Ceremony
• Judy Faulkner, Epic
• Alexis C. Komor, UCSD
What’s Next at Epic?
• Judy Faulkner, Epic
• Peter DeVault, Epic
RNA Therapeutics Beyond mRNA: siRNA, ASOs, and snRNA
• Chair: Alexis C. Komor, UCSD
• Niren Murthy, UC Berkeley
• Gene Yeo, UCSD
• Reuben Harris, UT Health San Antonio
Stem Cell-Targeted Therapeutics: Small Molecules & Biologics
• Chair: Catriona Jamieson, UCSD
• Irving L. Weissman, Stanford
Space-Omics & Stem-Cell Adaptation
• Chair: Catriona Jamieson, UCSD
• Alysson Muotri, UCSD
In Vivo Gene Therapies
• Chair: Gene Yeo, UCSD
• Mark A Kay, Stanford
• David Schaffer, UC Berkeley
Diagnostics, Prognostics, and Patient Stratification
• Chair: Ezra Cohen, Tempus
• Gudrun Stengel, Alida Biosciences
• Jarret Glasscock, Cofactor Genomics
• "Phil Febbo, Veracyte
Bioprinting Transplantable Liver: mRNA-Driven Multi-Lineage Differentiation from Autologous iPSCs
• Jiwu Wang, The Scintillon Institute
A New Era in Heart Failure Treatment: Delivering on the Promise of iPSC-Derived Cardiomyocyte Therapy
• Eugene Wang, Help Therapeutics
Closing Talk
• Catriona Jamieson, UCSD
